Nanotechnology in cell replacement therapies for type 1 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanotechnology in cell replacement therapies for type 1 diabetes

Published:2019-01 Issue: Volume:139 Page:116-138
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Ernst Alexander U.,Bowers Daniel T.,Wang Long-Hai,Shariati Kaavian,Plesser Mitchell D.,Brown Natalie K.,Mehrabyan Tigran,Ma Minglin

Funder

Hartwell Foundation

Novo Nordisk

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference440 articles.

1. Type 1 diabetes;Atkinson;Lancet,2014

2. Type 1 diabetes;DiMeglio;Lancet,2018

3. Current state of type 1 diabetes treatment in the U.S.: Updated data from the T1D exchange clinic registry;Miller;Diabetes Care,2015

4. Hypoglycemia, but not glucose variability, relates to vascular function in children with type 1 diabetes;Peña;Diabetes Technol. Ther.,2012

5. Biochemistry and molecular cell biology of diabetic complications;Brownlee;Nature,2001

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanically reinforced hydrogel vehicle delivering angiogenic factor for beta cell therapy;Journal of Colloid and Interface Science;2024-08

2. Immunoprotection Strategies in β‐Cell Replacement Therapy: A Closer Look at Porcine Islet Xenotransplantation;Advanced Science;2024-06-17

3. A Glucose‐Responsive Cannula for Automated and Electronics‐Free Insulin Delivery;Advanced Materials;2024-04-29

4. Characterizing an injectable alginate hydrogel as a co‐encapsulating system for beta cells and curcumin in type 1 diabetes therapy;The Canadian Journal of Chemical Engineering;2024-04-28

5. Advances in the Use of Biologics and Biomaterials toward the Improvement of Pancreatic Islet Graft Survival in Type 1 Diabetes;Advanced NanoBiomed Research;2024-01-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3